NASDAQ: MYGN       Myriad Genetics Inc
Last Price Today's Change   Day's Range   Trading Volume
26.20   +0.40 (1.55%)  24.715 - 26.29  125,943


Avg Volume (4 weeks):995,522
4 Weeks Range:17.40 - 27.34
4 Weeks Price Volatility (%):
52 Weeks Range:9.24 - 30.13
52 Weeks Price Volatility (%):
Average Price Target: 40.00
Price Target Upside/Downside: +13.80


No recent Headlines for this stock.

Business Background

Myriad Genetics, Inc. is a molecular diagnostic company. The Company is engaged in the discovery, development and marketing of transformative molecular diagnostic tests. The Company operates through two segments: diagnostics and other. The diagnostics segment provides testing and collaborative development of testing that is designed to assess an individual's risk for developing disease later in life, identify a patient's likelihood of responding to drug therapy and guide a patient's dosing to enable optimal treatment, or assess a patient's risk of disease progression and disease recurrence. The other segment provides testing products and services to the pharmaceutical, biotechnology and medical research industries, research and development, and clinical services for patients, and also includes corporate services, such as finance, human resources, legal and information technology. Its molecular diagnostic tests include myRisk Hereditary Cancer, BRACAnalysis CDx and COLARIS.

  Be the first to like this.

I3 Messenger
Individual or Group chat with anyone on I3investor

1816  4431  379  3253 

Top 10 Active Counters
 SNDL 0.716+0.026 
 LK 1.38+1.38 
 WPX 9.43+0.48 
 BNGO 8.57+1.62 
 CTRM 0.333-0.027 
 AVGR 1.45+0.34 
 BB 10.589+1.479 
 NIO 57.80-3.07 
 TLRY 19.86+1.30 
 OBSV 3.845+1.325 


1. Daily Futures Trading Strategy 15 January 2021 Where Futures Lies
2. Equities Retreated on Waning Optimism State of The Markets
3. CryptoNews of the Week CryptoNews
4. Markets Mixed on Hedging State of The Markets
5. Impeachment, Stimulus And The Markets Wall Street Breakfast